| Nov 12 |
Amgen slips as Cantor cites safety concerns linked to obesity candidate
|
| Nov 8 |
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
|
| Nov 8 |
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
|
| Nov 8 |
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
|
| Nov 8 |
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
|
| Nov 8 |
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
|
| Nov 7 |
Amgen Insiders Sold US$4.0m Of Shares Suggesting Hesitancy
|
| Nov 6 |
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
| Nov 5 |
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
|
| Nov 4 |
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?
|
